As of 2026-04-03, the EV/EBITDA ratio of Acerus Pharmaceuticals Corporation (ASP.TO) is -2.43. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. ASP.TO's latest enterprise value is 62.67 mil CAD. ASP.TO's TTM EBITDA according to its financial statements is -25.78 mil CAD. Dividing these 2 quantities gives us the above ASP.TO EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | 3.4x - 4.5x | 4.3x |
| Forward P/E multiples | 3.4x - 5.2x | 4.3x |
| Fair Price | (23.76) - (28.68) | (27.75) |
| Upside | -6699.4% - -8067.8% | -7809.6% |
| Date | EV/EBITDA |